ClinicalTrials.Veeva

Menu

The Effect of Supplementation of Flaxseed, Hesperidin, Flaxseed and Hesperidin Together in Metabolic Syndrome

N

National Nutrition and Food Technology Institute

Status

Unknown

Conditions

Metabolic Syndrome

Treatments

Other: control
Dietary Supplement: hesperidin
Dietary Supplement: hesperidin and flaxseed
Dietary Supplement: flaxseed

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

To study the effects of Hesperidin, flaxseed and both together in patients with metabolic syndrome, 100 patients will be randomly allocated to one of following four groups: control group, hesperidin group (2 capsules Hesperidin), flaxseed group (30 gram flaxseed) or flaxseed-hesperidin group (2 capsules Hesperidin and 30 gram flaxseed) for 12 weeks; both groups will be advised to adherence the investigators' diet and exercise program too. At the first and the end of the intervention, metabolic factors will be assessed and compared between groups.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age of 18 to 70 years
  • having 3 of 5 of high blood sugar, hypertension, high TG, high waist circumference, low HD

Exclusion criteria

  • pregnancy or lactation
  • history of Cardiovascular disease, Pulmonary disease, Renal disease & Celiac disease; Cirrhosis
  • Following a program to lose weight in recent 3 mo

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 4 patient groups, including a placebo group

hesperidin and flaxseed
Active Comparator group
Description:
1000 mg hesperidin as two capsules and 30 grams flaxseed
Treatment:
Dietary Supplement: hesperidin and flaxseed
control
Placebo Comparator group
Description:
no supplementation
Treatment:
Other: control
flaxseed
Active Comparator group
Description:
30 grams flaxseed
Treatment:
Dietary Supplement: flaxseed
hesperidin
Active Comparator group
Description:
1000 mg hesperidin as two capsules
Treatment:
Dietary Supplement: hesperidin

Trial contacts and locations

1

Loading...

Central trial contact

azita Hekmatdoost, MD.PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems